Literature DB >> 20945055

[Dithiols as chelators. A cause of bullous skin reactions].

J Storim1, J Stoevesandt, D Anders, H Kneitz, E-B Bröcker, A Trautmann.   

Abstract

Chelation therapy with (RS)-2,3-Bis(sulfonyl)propane-1-sulfonic acid (DMPS) after an occupational lead exposure led to the development of a severe bullous drug eruption. Skin tests and histology/immunohistology of the test reactions indicated a T-cell-mediated immune response against DMPS. Metal-binding thiol groups as in DMPS are chemically highly reactive and therefore effectively mediate the development of immunogenic hapten (DMPS)-protein complexes. Therefore, the pharmacological effects and sensitization potential of dithiols are tightly connected. Cross-reactivity of DMPS to other chelators like D-penicillamine is possible; the indications for chelation therapy should be weighed carefully.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20945055     DOI: 10.1007/s00105-010-1993-9

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  7 in total

Review 1.  Stevens-Johnson syndrome: pathogenesis, diagnosis, and management.

Authors:  Ribhi Hazin; Omar A Ibrahimi; Moustafa I Hazin; Arash Kimyai-Asadi
Journal:  Ann Med       Date:  2008       Impact factor: 4.709

Review 2.  Penicillamine-induced bullous dermatoses.

Authors:  A Bialy-Golan; S Brenner
Journal:  J Am Acad Dermatol       Date:  1996-11       Impact factor: 11.527

3.  The Mt. Diwata study on the Philippines 2000-treatment of mercury intoxicated inhabitants of a gold mining area with DMPS (2,3-dimercapto-1-propane-sulfonic acid, Dimaval).

Authors:  S Böse-O'Reilly; G Drasch; C Beinhoff; S Maydl; M R Vosko; G Roider; D Dzaja
Journal:  Sci Total Environ       Date:  2003-05-20       Impact factor: 7.963

Review 4.  Differential diagnosis of severe cutaneous drug eruptions.

Authors:  Nicolas Bachot; Jean-Claude Roujeau
Journal:  Am J Clin Dermatol       Date:  2003       Impact factor: 7.403

5.  Anticopper efficacy of captopril and sodium dimercaptosulphonate in patients with Wilson's disease.

Authors:  Xiao-Ping Wang; Ren-Min Yang; Ming-Shan Ren; Bo-Min Sun
Journal:  Funct Neurol       Date:  2003 Jul-Sep

Review 6.  Recommendations for medical management of adult lead exposure.

Authors:  Michael J Kosnett; Richard P Wedeen; Stephen J Rothenberg; Karen L Hipkins; Barbara L Materna; Brian S Schwartz; Howard Hu; Alan Woolf
Journal:  Environ Health Perspect       Date:  2006-12-22       Impact factor: 9.031

7.  [Lead poisoning after ingestion of ayurvedic drugs].

Authors:  Ulrike Schilling; Rudolf Mück; Else Heidemann
Journal:  Med Klin (Munich)       Date:  2004-08-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.